SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January 5, 2001
LIFECELL CORPORATION
(Exact Name of Registrant as Specified in Charter)
Delaware 01-19890 76-0172936
(State Or Other (Commission (IRS Employer
Jurisdiction Of File Number) Identification No.)
Incorporation). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
One Millenium Way
Branchburg, New Jersey 08876
---------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (908) 947-1100
<PAGE>
Item 5. Other Events.
On January 5, 2001, LifeCell Corporation issued the press release attached
to this Current Report on Form 8-K as Exhibit 99.1.
Item 7. Financial Statements and Exhibits.
(c) Exhibits
99.1 Press release dated January 5, 2001.
-2-
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
LIFECELL CORPORATION
By:
----------------------
Steven T. Sobieski
Chief Financial Officer
Date: January 5, 2001
-3-
<PAGE>
